Trend Results : Cancer Center


Blog Post Results (1-20 of 3144)

FILTER RESULTS

The HPV Vaccine Prevents Cancer. So Why Aren't Most Teens Getting It?

According to latest National Immunization Survey, released by the Centers for Disease Control and Prevention Thursday, around 60 percent of teenage girls and 78 percent of teenage boys haven't received all three of the recommended doses...Show More Summary

New Mathematical Model Developed That Can Acccurately Predict the Amount of Nicotine Emitted From E-Cigarettes

Virginia Commonwealth University Massey Cancer Center researchers at the VCU Center for the Study of Tobacco Products (CSTP) have developed the first ever, evidence-based model that can predict with up to 90 percent accuracy the amount of nicotine emitted by an electronic cigarette (e-cigarette).

Moffitt Cancer Center Teams Up with MD Anderson to Discover, Test Novel Agents to Prevent Cancer

Moffitt Cancer Center has joined MD Anderson's National Cancer Institute (NCI) Phase 0/I/II Cancer Prevention Clinical Chemoprevention Trials Consortia. Sponsored by the NCI's Division of Cancer Prevention, the consortia conducts early clinical development of promising new preventive agents through its Phase 0/I/II Cancer Prevention Clinical Trials Program.

The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation

The Tisch Cancer Institute (TCI) at the Icahn School of Medicine at Mount Sinai has been named a National Cancer Institute (NCI)-designated cancer center. TCI joins an elite group of 69 cancer institutions nationwide that have earned this designation, which is based on scientific excellence, robust clinical research, and beneficial community impact.

NYU's Bluestone Center Receives a $369,250 High Priority, Short-Term Project Award from NIDCR to Study Oral Cancer Pain

The proposed studies are designed to test whether nonviral gene delivery into the oral cancer could be used to treat cancer pain effectively and safely.

Guantanamo Lawyers’ Alarmingly High Cancer Rate Sparks Military Investigation

Originally published at MintPress News. GUANTANAMO BAY, Cuba — Despite promises to close the detention center during Barack Obama’s presidential run, the prison at the Guantanamo Bay naval base remains open. And now it appears those detained at the controversial site aren’t the only ones suffering and dying — their lawyers are also facing grave...

Cancer Survivorship 101: Identifying Your Emotions

It was a normal Friday, I was outside playing with our three girls and walked over to the mailbox to grab the mail and there it was. An envelope addressed to me from a radiation and imaging center. I wanted to scream right then and there. Show More Summary

Scientists Identify Gene Vital for Rebuilding Intestine After Cancer Treatment

Scientists at the UNC School of Medicine and the UNC Lineberger Comprehensive Cancer Center found that a rare type of stem cell is immune to radiation damage thanks to high levels of a gene called Sox9.

New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments

Article in journal Bioinformatics from University of Colorado Cancer Center describes a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.

Clinical validation for LOXO-101 against TRK fusion cancer

Loxo Oncology, Inc. and The University of Colorado Cancer Center today announced the publication of a research brief describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development. Show More Summary

UNM Cancer Center Scientists Discover that an Anti-Inflammatory Drug Acts Against Ovarian Cancer

A team of scientists at the University of New Mexico Cancer Center published a research paper showing that a non-steroidal anti-inflammatory drug (NSAID) called ketorolac helped women with ovarian cancer to survive longer.

Cancer Healthcare Disparities Exist in the LGBTQ Community, Say Moffitt Cancer Center Researchers

The Lesbian, Gay, Bisexual, Transgender/Transsexual, Queer/Questioning (LGBTQ) community is a growing and medically-underserved minority population in the United States, with 3 to 12 percent of the population estimated to identify as LGBTQ. Show More Summary

Race and Institutional Factors Play an Important Role in Pharmacogenomic Trial Participation, Say Moffitt Cancer Center Researchers

Moffitt Cancer Center researchers have published a study in the Journal of the National Cancer Institute that analyzed the participation rate of patients in pharmacogenomic trials.

University of Colorado Cancer Center and Loxo Oncology Announce Publication That Provides Clinical Validation For LOXO-101 Against TRK Fusion Cancer

Published today in Cancer Discovery, results of LOXO-101 against TRK fusion cancer confirm that stage IV patient's tumors had substantially regressed. With four months of treatment, additional CT scans demonstrated almost complete disappearance of the largest tumors.

David Adjaye Designs an Elegant Children's Cancer Center in Rwanda

Architecture for humanity. While design can't cure disease, it does have the ability to soothe, to comfort, and to create joy—powerful sentiments that can make treatment less miserable. Architect David Adjaye's new project, the Eugene Gasana Jr. Show More Summary

Moffitt Cancer Center Researchers Develop First Genetic Test to Predict Tumor Sensitivity to Radiation Therapy

Moffitt Cancer Center researchers have contributed to these advances by developing the first test that analyzes the sensitivity of tumors to radiation therapy. They discovered that colon cancer metastases have varying sensitivity to radiation therapy based on their anatomic location.

This woman finished chemo, so the Wisconsin marching band showed up to celebrate

Ann Trachtenberg was joking around when she said she wanted a marching band to show up for her final chemotherapy treatment, the University of Wisconsin Carbone Cancer Center wrote on its Facebook page. Still, even if it was a joke, it’s also a pretty good idea, right? When Trachtenberg walked out of the center, she was met […]

Wisconsin marching band surprises cancer patient after she completes last round of chemo

According to the UW Carbone Cancer Center, patient Ann Trachtenberg joked that she wanted a marching band to escort her out of her last (...)

Roche Earnings Are Likely To Show Resistance Against Competition

The company’s business is primarily centered around its cancer drugs which are biologics and have enjoyed little competition so far. But the looming threat from biosimilars and a stronger-than-usual push from other big pharma firms in immuno-oncology research have cast uncertainty over Roche’s future growth. Show More Summary

MD Anderson Named as One of Two Genome Characterization Centers

The University of Texas MD Anderson Cancer Center has been named a site for one of two new Genome Characterization Centers (GCC) funded through the National Cancer Institute (NCI).

Copyright © 2015 Regator, LLC